These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34083167)

  • 41. The evolution of chest pain pathways.
    Mangleson FI; Cullen L; Scott AC
    Crit Pathw Cardiol; 2011 Jun; 10(2):69-75. PubMed ID: 21988946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control.
    Andriolo G; Provasi E; Brambilla A; Lo Cicero V; Soncin S; Barile L; Turchetto L; Radrizzani M
    Methods Mol Biol; 2021; 2286():131-166. PubMed ID: 33381854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19: Commentary on: "COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine" by Siniscalchi M et al. Dig Liv Dis 2020;52:1071-5.
    Ines Pinto-Sanchez M; Lebwohl B
    Dig Liver Dis; 2020 Oct; 52(10):1069-1070. PubMed ID: 32553700
    [No Abstract]   [Full Text] [Related]  

  • 44. Early experience of implantation of the new CoreValve(®) Evolut(™) in degenerated bioprosthetic aortic valves.
    Fairley SL; Jeganathan R; Manoharan G; Spence MS
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):485-92. PubMed ID: 23857751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of the Doppler-derived pressure gradient in pediatric patients with aortic valvular stenosis: is the correction for pressure recovery necessary?
    Yamazawa H
    Hokkaido Igaku Zasshi; 2010 Jul; 85(4):225-31. PubMed ID: 20718206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.
    Płońska-Gościniak E; Suwalski P; Bartuś S; Kukulski T; Komar M; Wojakowski W; Grygier M; Pruszczyk P; Gąsior Z; Huczek Z; Berger-Kucza A; Bąk J; Sorysz D; Kasprzak JD
    Kardiol Pol; 2020 May; 78(5):498-507. PubMed ID: 32415767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response by Simard et al to Letter Regarding Article, "Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?".
    Simard L; Côté N; Mathieu P; Clavel MA
    Circ Res; 2017 Mar; 120(5):e26. PubMed ID: 28254806
    [No Abstract]   [Full Text] [Related]  

  • 48. Patient Use and Clinical Practice Patterns of Remote Cardiology Clinic Visits in the Era of COVID-19.
    Yuan N; Pevnick JM; Botting PG; Elad Y; Miller SJ; Cheng S; Ebinger JE
    JAMA Netw Open; 2021 Apr; 4(4):e214157. PubMed ID: 33818619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reply to "Relation between the cell differentiation degree of colorectal cancer and its topographic distribution". (Linares E, et al. Rev Esp Enferm Dig 2002; 94(2): 78-87) [corrected].
    Linares Santiago E
    Rev Esp Enferm Dig; 2002 Sep; 94(9):568; author reply 568-9. PubMed ID: 12587241
    [No Abstract]   [Full Text] [Related]  

  • 50. Valvular heart disease: the influence of changing etiology on nosology.
    Boudoulas H; Vavuranakis M; Wooley CF
    J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phentermine cardiovascular safety II: response to Yosefy Int J Cardiol. 2009 Epub Mar 19.
    Rothman RB; Hendricks EJ
    Int J Cardiol; 2010 Nov; 145(2):391-392. PubMed ID: 20207432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient with valvular disease: evolving care patterns.
    Lurz P; Senni M; Guérin P
    Eur Heart J Suppl; 2020 Dec; 22(Suppl Pt t):P42-P46. PubMed ID: 33390870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telemedicine in India: A tool for transforming health care in the era of COVID-19 pandemic.
    Agarwal N; Jain P; Pathak R; Gupta R
    J Educ Health Promot; 2020; 9():190. PubMed ID: 32953916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2).
    Bhaskar S; Bradley S; Chattu VK; Adisesh A; Nurtazina A; Kyrykbayeva S; Sakhamuri S; Moguilner S; Pandya S; Schroeder S; Banach M; Ray D
    Front Public Health; 2020; 8():410. PubMed ID: 33014958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valvular heart disease and anaesthesia.
    Paul A; Das S
    Indian J Anaesth; 2017 Sep; 61(9):721-727. PubMed ID: 28970630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial ventricular septal defect (Pacman Heart).
    Pujol E; Morales M; Roelandt JR; Pérez MJ; Masià R; Sala J; Geleijnse ML
    Eur J Echocardiogr; 2008 Mar; 9(2):316-7. PubMed ID: 18490325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to Smith et al.: Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).
    Scott RE; Mars M
    J Telemed Telecare; 2020 Jul; 26(6):378-380. PubMed ID: 32525438
    [No Abstract]   [Full Text] [Related]  

  • 58. The Technological Impact of COVID-19 on the Future of Education and Health Care Delivery.
    Shah S; Diwan S; Kohan L; Rosenblum D; Gharibo C; Soin A; Sulindro A; Nguyen Q; Provenzano DA
    Pain Physician; 2020 Aug; 23(4S):S367-S380. PubMed ID: 32942794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erratum to "Letter to editor in response to "COVID-19: From bench to bedside" by Singh A et al." [Diabetes & Metab Syndrome: Clin Res Rev 14 (5) (2020) 815-816 of duplicate article].
    Singh H; Prasad Dhibar D
    Diabetes Metab Syndr; 2020; 14(5):1597. PubMed ID: 32937729
    [No Abstract]   [Full Text] [Related]  

  • 60. Reclassification of Xanthomonas campestris pv. citri (ex Hasse 1915) Dye 1978 forms A, B/C/D, and E as X. smithii subsp. citri (ex Hasse) sp. nov. nom. rev. comb. nov., X. fuscans subsp. aurantifolii (ex Gabriel 1989) sp. nov. nom. rev. comb. nov., and X. alfalfae subsp. citrumelo (ex Riker and Jones) Gabriel et al., 1989 sp. nov. nom. rev. comb. nov.; X. campestris pv malvacearum (ex smith 1901) Dye 1978 as X. smithii subsp. smithii nov. comb. nov. nom. nov.; X. campestris pv. alfalfae (ex Riker and Jones, 1935) dye 1978 as X. alfalfae subsp. alfalfae (ex Riker et al., 1935) sp. nov. nom. rev.; and "var. fuscans" of X. campestris pv. phaseoli (ex Smith, 1987) Dye 1978 as X. fuscans subsp. fuscans sp. nov.
    Schaad NW; Postnikova E; Lacy GH; Sechler A; Agarkova I; Stromberg PE; Stromberg VK; Vidaver AK
    Syst Appl Microbiol; 2005 Aug; 28(6):494-518. PubMed ID: 16104350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.